Trial Profile
Phase II Study of Intensive Induction (R-MegaCHOP/ESHAP)Followed By Intensive Consolidation (BEAM) In Treatment Of High-Risk Aggressive B-Cell Lymphomas
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Mar 2013
Price :
$35
*
At a glance
- Drugs Carmustine (Primary) ; Cisplatin (Primary) ; Cyclophosphamide (Primary) ; Cytarabine (Primary) ; Doxorubicin (Primary) ; Etoposide (Primary) ; Melphalan (Primary) ; Methylprednisolone (Primary) ; Prednisone (Primary) ; Rituximab (Primary) ; Vincristine (Primary)
- Indications B-cell lymphoma; Diffuse large B cell lymphoma; Follicular lymphoma
- Focus Therapeutic Use
- 03 Jun 2009 New trial record.